Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

111.84
Delayed Data
As of Jan 20
 -0.37 / -0.33%
Today’s Change
67.81
Today|||52-Week Range
132.95
-0.75%
Year-to-Date
No recent news for Abiomed Inc.

Today’s Trading

Previous close112.21
Today’s open112.00
Day’s range110.83 - 112.30
Volume388,409
Average volume (3 months)498,328
Market cap$4.9B
Dividend yield--
Data as of 3:59pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-67.92%
Earnings growth (this year)+33.18%
Earnings growth (next 5 years)+25.50%
Revenue growth (last year)+43.09%
P/E ratio115.3
Price/Sales12.92
Price/Book12.96

Competitors

 Today’s
change
Today’s
% change
WSTWest Pharmaceutical ...-0.18-0.22%
MASIMasimo Corp-0.26-0.36%
NUVANuVasive Inc+0.30+0.43%
IARTIntegra LifeSciences...-0.50-1.19%
Data as of 4:02pm ET, 01/20/2017

Financials

Next reporting dateJanuary 26, 2017
EPS forecast (this quarter)$0.29
Annual revenue (last year)$329.5M
Annual profit (last year)$38.1M
Net profit margin11.58%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts


Search for Jobs